New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export NVO’s income statement to Excel — free account
Novo Nordisk A/S
NVOHealthcare Drug Manufacturers General
Novo Nordisk A/S’s revenue for fiscal 2025 (year ended December 2025) was $46.8 billion, up 11.1% from fiscal 2024.
- Revenue
- +3.87%
- EPS
- −17.1%
- Free cash flow
- −14.8%
- Total debt
- +30.7%
Quarter to September 2026, against a year earlier
38.57
0.32
−0.82%
Follow NVO
Alert me
Revenue to profit Fiscal 2025, year to Dec 31, 2025
Of every $100 of revenue, $33.14 was left as profit. What is an income statement?
| Revenue | 46.8 | 100.0% |
|---|---|---|
| Cost of revenue | −8.9 | −19.0% |
| Gross profit | 37.9 | 81.0% |
| Research & development | −7.9 | −16.8% |
| Selling, general & admin | −10.6 | −22.7% |
| Operating income | 19.3 | 41.3% |
| Other income, net | +0.4 | 0.9% |
| Income tax | −4.3 | −9.1% |
| Net income | 15.5 | 33.1% |
Net margin (right axis)
| FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $16.6B | $17.0B | $17.1B | $18.3B | $19.4B | $22.4B | $25.1B | $33.7B | $42.1B | $46.8B |
| Operating income | $7.2B | $7.4B | $7.2B | $7.9B | $8.3B | $9.3B | $10.6B | $14.9B | $18.6B | $19.3B |
| Net income | $5.6B | $5.8B | $5.9B | $5.8B | $6.5B | $7.6B | $7.9B | $12.2B | $14.6B | $15.5B |
| Net margin (right axis) | 33.9% | 34.1% | 34.5% | 31.9% | 33.2% | 33.9% | 31.4% | 36.0% | 34.8% | 33.1% |
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue |
46,792.29 | 42,108.43 | 33,724.30 | 25,056.69 | 22,401.28 | 19,448.13 | 18,290.95 | 17,098.96 | 16,966.62 | 16,610.51 |
Revenue Growth |
11.12% | 24.86% | 34.59% | 11.85% | 15.18% | 6.33% | 6.97% | 0.78% | 2.14% | 3.43% |
Cost of Revenue |
8,900.50 | 6,455.69 | 5,193.08 | 4,028.24 | 3,763.99 | 3,206.78 | 3,011.19 | 2,693.64 | 2,678.30 | 2,553.39 |
Gross Profit |
37,891.79 | 35,652.74 | 28,531.22 | 21,028.45 | 18,637.29 | 16,241.34 | 15,279.76 | 14,405.32 | 14,288.32 | 14,057.11 |
R&D Expenses |
7,878.71 | 6,968.99 | 4,710.72 | 3,405.06 | 2,827.53 | 2,368.78 | 2,131.58 | 2,263.69 | 2,128.73 | 2,164.06 |
SG&A Expenses |
10,640.24 | 9,769.67 | 8,944.03 | 7,176.85 | 6,532.33 | 5,650.94 | 5,370.92 | 5,093.56 | 4,879.64 | 4,805.58 |
Operating Income |
19,327.42 | 18,609.15 | 14,893.74 | 10,592.95 | 9,330.26 | 8,292.10 | 7,867.20 | 7,224.22 | 7,438.09 | 7,197.00 |
Non-operating Income/Expense |
436.33 | (166.46) | 304.92 | (813.78) | 69.37 | (152.59) | (589.11) | 56.11 | (43.60) | (94.21) |
Non-operating Interest Expenses |
1,026.19 | 1,065.17 | 122.69 | 847.62 | 389.95 | 402.00 | 598.85 | 268.34 | 232.86 | 107.88 |
| 19,763.76 | 18,442.70 | 15,198.67 | 9,779.18 | 9,399.63 | 8,139.52 | 7,278.10 | 7,280.33 | 7,394.49 | 7,102.78 | |
Income Tax Provision |
4,255.25 | 3,799.44 | 3,047.89 | 1,916.84 | 1,801.49 | 1,683.97 | 1,439.34 | 1,374.11 | 1,602.55 | 1,467.13 |
Income after Tax |
15,508.51 | 14,643.26 | 12,150.77 | 7,862.34 | 7,598.14 | 6,455.54 | 5,838.76 | 5,906.22 | 5,791.95 | 5,635.66 |
Dividends (Preferred) |
— | — | — | 0.00 | — | 0.00 | — | — | 0.00 | — |
Net Income Common |
15,508.51 | 14,643.26 | 12,150.77 | 7,862.34 | 7,598.14 | 6,455.54 | 5,838.76 | 5,906.22 | 5,791.95 | 5,635.66 |
EPS (Basic) |
3.49 | 3.29 | 2.71 | 1.74 | 1.66 | 1.39 | 1.23 | 1.27 | 1.17 | 1.07 |
EPS (Diluted) |
3.49 | 3.28 | 2.70 | 1.73 | 1.65 | 1.38 | 1.23 | 1.26 | 1.17 | 1.07 |
Shares (Basic, Weighted) |
4,443.00 | 4,453.90 | 4,482.80 | 4,530.60 | 4,593.80 | 4,667.80 | 4,748.60 | 4,839.21 | 4,946.44 | 5,059.89 |
Shares (Diluted, Weighted) |
4,447.70 | 4,463.00 | 4,494.80 | 4,544.60 | 4,604.93 | 4,680.00 | 4,757.32 | 4,848.83 | 4,956.19 | 5,069.46 |
Gross Margin |
80.98% | 84.67% | 84.60% | 83.92% | 83.20% | 83.51% | 83.54% | 84.25% | 84.21% | 84.63% |
EBIT Margin |
41.30% | 44.19% | 44.16% | 42.28% | 41.65% | 42.64% | 43.01% | 42.25% | 43.84% | 43.33% |
EBT margin |
42.24% | 43.80% | 45.07% | 39.03% | 41.96% | 41.85% | 39.79% | 42.58% | 43.58% | 42.76% |
Net Profit Margin |
33.14% | 34.78% | 36.03% | 31.38% | 33.92% | 33.19% | 31.92% | 34.54% | 34.14% | 33.93% |
Free Cash Flow Margin |
9.38% | 23.99% | 30.14% | 36.24% | 33.82% | 23.54% | 29.14% | 28.81% | 29.12% | 35.83% |
EBITDA |
22,655.50 | 21,379.67 | 16,260.51 | 11,635.41 | 10,288.84 | 9,173.46 | 8,715.79 | 7,824.35 | 7,921.43 | 7,671.48 |
EBIT |
19,327.42 | 18,609.15 | 14,893.74 | 10,592.95 | 9,330.26 | 8,292.10 | 7,867.20 | 7,224.22 | 7,438.09 | 7,197.00 |
Income from Continuous Operations |
15,508.51 | 14,643.26 | 12,150.77 | 7,862.34 | 7,598.14 | 6,455.54 | 5,838.76 | 5,906.22 | 5,791.95 | 5,635.66 |
Consolidated Net Income/Loss |
15,508.51 | 14,643.26 | 12,150.77 | 7,862.34 | 7,598.14 | 6,455.54 | 5,838.76 | 5,906.22 | 5,791.95 | 5,635.66 |
EPS (Basic, from Continuous Ops) |
3.49 | 3.29 | 2.71 | 1.74 | 1.65 | 1.38 | 1.23 | 1.22 | 1.17 | 1.11 |
EPS (Basic, Consolidated) |
3.49 | 3.29 | 2.71 | 1.74 | 1.65 | 1.38 | 1.23 | 1.22 | 1.17 | 1.11 |
EPS (Diluted, from Cont. Ops) |
3.49 | 3.28 | 2.70 | 1.73 | 1.65 | 1.38 | 1.23 | 1.22 | 1.17 | 1.11 |
Shares (Diluted, Average) |
4,442.06 | 4,463.00 | 4,494.25 | 4,543.78 | 4,594.23 | 4,669.03 | 4,755.92 | 4,849.72 | 4,955.17 | 5,060.04 |
EPS (Diluted, Consolidated) |
3.49 | 3.28 | 2.70 | 1.73 | 1.65 | 1.38 | 1.23 | 1.22 | 1.17 | 1.11 |
EBITDA Margin |
48.42% | 50.77% | 48.22% | 46.44% | 45.93% | 47.17% | 47.65% | 45.76% | 46.69% | 46.18% |
Operating Cash Flow Margin |
38.54% | 41.66% | 46.89% | 44.58% | 39.06% | 40.92% | 38.34% | 39.90% | 36.86% | 43.22% |
In millions of $ except per-share values · columns are period end dates · fundamentals updated Nov 18, 2026